Title: Metformin Shows Promise in Reducing the Risk of Long Covid, Study Finds
Many people continue to experience the aftereffects of COVID-19, even after their expected recovery period. This lingering condition, known as Long Covid, encompasses a range of persistent and new symptoms that can last for weeks, months, or even years. Fatigue, shortness of breath, loss of smell, muscle aches, memory and concentration problems, chest pain, heart palpitations, insomnia, and mental health issues are among the common symptoms reported by Long Covid sufferers.
In a new study published in The Lancet, researchers have found a potential solution to reduce the risk of Long Covid: the medication Metformin, commonly used for type 2 diabetes. The study involved 1,431 participants aged 30 to 85, the majority of whom were overweight or obese. The results showed that those who received Metformin within four days of symptom onset had a remarkable 63% reduction in the risk of developing Long Covid. Even if Metformin was administered after this initial period, there was still a significant 42% decrease in risk.
Metformin is already known for its benefits in regulating glucose levels in patients with type 2 diabetes. However, it also possesses antiviral, anti-inflammatory, and anti-thrombotic properties, which may explain its potential effectiveness in preventing Long Covid.
Despite the promising findings, it is important to approach the study with caution. The research relied on participant-reported symptoms, which can be subjective and prone to biases. Therefore, further evaluation in a broader population is necessary before drawing definitive conclusions about the effects of Metformin on Long Covid.
In addition to Metformin, there are other potential interventions that can help prevent Long Covid. One such option is the antiviral medicine Paxlovid, along with adherence to proven hygiene practices. Moreover, self-care plays a crucial role in managing Long Covid symptoms. Maintaining good sleep, a healthy diet, and practicing mindfulness have been shown to be beneficial.
It is crucial to note that while Metformin may prevent Long Covid in some cases, it may not be as helpful for those who are already experiencing the condition. Therefore, individuals should always consult with their healthcare provider for personalized medical advice.
Various organizations, such as the British Heart Foundation, have also produced recovery guides to assist individuals in managing Long Covid symptoms and boosting their mental health. Some cases have shown that beta blockers can effectively manage symptoms like exercise intolerance and a fast heart rate associated with Long Covid.
In conclusion, the study’s findings suggest that Metformin may hold promise in reducing the risk of Long Covid. However, further research is needed to validate these preliminary results. While waiting for more conclusive evidence, individuals should focus on self-care and seek professional medical advice when needed to manage Long Covid symptoms effectively.